Cancer Research UK tests first of its kind vaccine to treat lung cancer
NHS England strikes deal on new NICE recommended lung cancer immunotherapy drug
Breast cancer gene test could spare some women chemo
Fewer men are being screened, diagnosed, and treated for prostate cancer
A new study reveals declines in prostate cancer screening and diagnoses in the United States in recent years, as well as decreases in the use of definitive treatments in men who have been diagnosed. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
HPV vaccine is safe and reduces cell changes that can become cancer
New treatment for myeloma receives second negative recommendation across Europe
Plitidepsin (Aplidin®), a new medicine for the treatment of relapsed and refractory myeloma, has received a second negative recommendation from the Committee for Medicinal Products for Human Use (CHMP). This decision means that plitidepsin is very unlikely to be made available to patients across Europe.